James A. Onori

Statistics

Publications

Citations

609

H-Index

Active since

1998

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

James A. Onori is an author at Research Triangle Park Foundation specializing in medicine, vascular endothelial growth factor inhibitors, and molecular oncology.

Publications per year

1998–2007

Publications

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

Rakesh Kumar, Victoria B. Knick, Sharon K. Rudolph et al. · Molecular Cancer Therapeutics · 2007 · 517 citations

Medicine, Pharmacokinetics, Pharmacology +17

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models

I K Dev, Ronna E. Dornsife, Teresa M. Hopper et al. · British Journal of Cancer · 2004 · 43 citations · Full text

Medicine, Oncology, Pharmacology +16

Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist

Diane M. Ignar, John L. Andrews, Samuel M. Witherspoon et al. · Clinical & Experimental Metastasis · 1998 · 35 citations

Medicine, Cancer Biology, Oncology +8

Correlation of anti-tumor and anti-angiogenic activity of VEGFR inhibitors with inhibition of VEGFR2 phosphorylation in mice

Rakesh Kumar, L.E. Harrington, Teresa M. Hopper et al. · Journal of Clinical Oncology · 2005 · 14 citations

Medicine, Oncology, Pharmacology +17

1–4 of 4